Sino Biopharmaceutical News and Activities

Sino Biopharmaceutical is owned by Charoen Pokphand Group.

Charoen Pokphand Group is a company listed under the stock ticker CPF (TH).

Charoen Pokphand Group has a direct presence in 4 countries.

Charoen Pokphand Group has 9 subsidiaries including Ascend Money, Bellisio Foods and Charoen Pokphand Foods.

They are in:

• Retail40%
• Food20%
• Other40%

View the org chart displaying its 16 main executives

Most searched biographies at Sino Biopharmaceutical

• Eric Tse, Executive Director and Chief Executive Officer
• Kwok Tung Li, Independent Non-Executive Director
• Hong Lu, Independent Non-Executive Director

Create your alert
to follow the executive moves at Sino Biopharmaceutical.

Charoen Pokphand Group has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Sino Biopharmaceutical

• Cheng Cheung Ling and Eric Tse Attend the Inaugural Hong Kong Embodied AI Industry Summit, Ushering in a New Era of Embodied AI Productivity-Sino Biopharm
• Culmerciclib Approved for First-Line Treatment of Breast Cancer! Sino Biopharm Advances CDK Therapy into a New Stage-Sino Biopharm
• Sino Biopharm and GlaxoSmithKline Forge Exclusive Strategic Partnership to Advance the World's First Blockbuster Drug for Curing Hepatitis B-Sino Biopharm
• Asia Summit on Global Health Opens, Theresa Tse: Pharmaceutical Innovation is a Marathon, Willing to Build an Open Ecosystem with Global Peers-Sino Biopharm
• Jointly Promoting New Development in China-UAE Economic and Trade Cooperation! China-UAE Business and Investment Promotion Conference Held in Beijing, Eric Tse Invited to Attend the Opening Ceremony-Sino Biopharm
• Sino Biopharmaceutical Enters the Era of Domesticated "10,000-Liter Scale" Biologic Production Lines-Sino Biopharm
• Xu Xiao, First Secretary of the Secretariat of the Central Committee of the Communist Youth League, Leads Delegation to Inspect Chia Tai Tianqing, Focusing on Innovative Development and Youth Talent Cultivation-Sino Biopharm
• Sino Biopharmaceutical's "Defu Combination" Approved for Fourth Indication, with an Objective Response Rate of 72.41%!-Sino Biopharm
• Authoritative Citeline Report: Sino Biopharmaceutical Ranks 14th Globally in Pipeline Scale, Demonstrating "Impressive Achievement"-Sino Biopharm
• Sino Biopharm Releases 2025 Annual Results: Revenue and Net Profit Maintain Double-Digit Growth, Innovative Product Revenue Exceeds RMB 15 Billion-Sino Biopharm
• View more press releases Close

Social media about Sino Biopharmaceutical

• Sino Biopharmaceutical on Wikipedia, Google News & Yahoo Finance
• Sino Biopharmaceutical on LinkedIn, X (Twitter) & YouTube